Uncategorized

It was the first round of the US Women's Open in Natthakritta Vongtaveelap's career, but it ended after just five holes after her caddy's gross mistake led to her disqualification from the tournament at Pebble Beach. The 20-year-old's caddy was seen using a rangefinder, which is prohibited at the US Open.USGA rules officer Kathryn Belanger said her caddy used the rangefinder "at least a couple of times", leading to a disqualification. If it was once, the penalty would have been two shots from Vongtaveelap's total score for the round. CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COM Natthakritta Vongtaveelap tees…

WANTAGH, NY — Off the coast of Long Island, drones sweep the ocean, patrolling the water for any danger that may lurk below the surface as beachgoers become more vigilant due to a recent series of encounters with sharks.Over two days this week, five people reported being bitten by sharks off some of New York's most popular beaches, prompting increased surveillance of the area's waters.The sighting of a 10-foot shark on Thursday prompted authorities to keep people out of the water at Robert Moses State Park, the same Long Island beach that delayed its July 4 opening after a drone…

Thanks to the start of a new month, there are a host of new movies and TV shows for UK subscribers to enjoy on Netflix this weekend. First off, here are some of the highlights of the week: BAM! (2023) north Director: chris smithGender: Music, Docuseries | Execution time: 92 minutesCast: George Michael Andrew Ridgeley Article continues below... Thanks to archived interviews and behind-the-scenes footage, fans of BAM! Relive the career of one of the most iconic '80s pop icons of all time! Young Sheldon (season 5) New episodes: 22Gender: Comedy | Execution time: 30 minutesCast: Iain Armitage, Zoe Perry,…

The Food and Drug Administration (FDA) granted full approval to a new Alzheimer's drug on Thursday, marking the first time the agency has approved a drug intended to slow the progression of the disease.The drug, called Leqembi, has been shown in clinical trials to slow the progression of Alzheimer's disease in people with mild cognitive impairment or early-stage disease. It is not a cure.Leqembi targets a type of protein in the brain called beta-amyloid, which scientists have long thought was a major cause of the disease. Leqembi.Eisai company.Given every two weeks as an infusion, patients will need to visit a…